Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Journal article
Voysey M. et al, (2021), The Lancet, 397, 99 - 111
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Journal article
Folegatti PM. et al, (2020), The Lancet, 396, 467 - 478
Use of gene expression studies to investigate the human immunological response to malaria infection
Journal article
Hodgson SH. et al, (2019), Malaria Journal, 18
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
Journal article
Tiono AB. et al, (2018), PLOS ONE, 13, e0208328 - e0208328
Plasmodium falciparum malaria parasite var gene expression is modified by host antibodies: longitudinal evidence from controlled infections of Kenyan adults with varying natural exposure
Journal article
Abdi AI. et al, (2017), BMC Infectious Diseases, 17
Role of Activins in Hepcidin Regulation during Malaria
Journal article
Spottiswoode N. et al, (2017), Infection and Immunity, 85
Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine
Journal article
Longley RJ. et al, (2017), Infection and Immunity, 85
Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants
Journal article
Bliss CM. et al, (2017), Molecular Therapy, 25, 547 - 559
Changes in Serological Immunology Measures in UK and Kenyan Adults Post-controlled Human Malaria Infection
Journal article
Hodgson SH. et al, (2016), Frontiers in Microbiology, 7
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants
Journal article
Afolabi MO. et al, (2016), Molecular Therapy, 24, 1470 - 1477
Demonstration of the Blood-StagePlasmodium falciparumControlled Human Malaria Infection Model to Assess Efficacy of theP. falciparumApical Membrane Antigen 1 Vaccine, FMP2.1/AS01
Journal article
Payne RO. et al, (2016), Journal of Infectious Diseases, 213, 1743 - 1751
Malaria: fluid therapy in severe disease.
Journal article
Hodgson SH. and Angus BJ., (2016), BMJ clinical evidence, 2016
Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya
Journal article
Hodgson SH. et al, (2015), Malaria Journal, 14
Standardization of the antibody-dependent respiratory burst assay with human neutrophils and Plasmodium falciparum malaria
Journal article
Llewellyn D. et al, (2015), Scientific Reports, 5
Assessment of FMP2.1/AS01B, an asexual blood-stage malaria vaccine, in a phase I/II a clinical trial using blood-stage controlled human malaria infection
Conference paper
Payne RO. et al, (2015), TROPICAL MEDICINE & INTERNATIONAL HEALTH, 20, 22 - 22
Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection againstPlasmodium falciparuminfection in Kenyan adults
Journal article
Ogwang C. et al, (2015), Science Translational Medicine, 7, 286re5 - 286re5
Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals
Journal article
Hodgson SH. et al, (2015), Journal of Infectious Diseases, 211, 1076 - 1086
Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies
Journal article
Hodgson SH. et al, (2015), Malaria Journal, 14, 33 - 33
A Phase Ia Study to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 CS Administered Alone and with MVA CS
Journal article
de Barra E. et al, (2014), PLoS ONE, 9, e115161 - e115161
Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection
Journal article
Hodgson SH. et al, (2014), Frontiers in Microbiology, 5